Appointed by President Trump to head the Food and Drug Administration, Gottlieb gained supporters for grounding his tough policies in scientific evidence. Last year, he pulled an opioid off the market because its addictive properties outweighed its painkilling benefits, and this year he addressed high drug prices by approving more generic versions and cracked down on e-cigarette makers and questionable stem-cell clinics. —Alice Park
Next Up
Most Popular Stories
More Coverage
More from TIME.com
TIME may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.